Concept Medical’s MagicTouch Sirolimus-Coated Devices Gain CE Mark Approval

 

October 18, 2019—Concept Medical has announced European CE Mark approval for its MagicTouch line of sirolimus-coated devices. These include the MagicTouch PTA, a sirolimus-coated percutaneous transluminal angioplasty (PTA) balloon catheter to treat peripheral artery disease (PAD); MagicTouch AVF, a sirolimus-coated PTA balloon catheter for treating complications from arteriovenous fistula and arteriovenous grafts; and MagicTouch ED, a sirolimus-coated balloon catheter for erectile dysfunction. The company will commercialize these products across Europe and in other markets that recognize CE Mark certification.

On August 29, Concept Medical announced that it had received FDA Breakthrough Device designation for the MagicTouch AVF device. On August 13, the company announced FDA Breakthrough Device designation for the MagicTouch PTA balloon catheter for the treatment of PAD below the knee.

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.